FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384119818> ?p ?o ?g. }

• W4384119818 endingPage "471" @default.
• W4384119818 startingPage "465" @default.
• W4384119818 abstract "Prostate cancer is the world's most frequently diagnosed malignancy in men. Recent work suggests that patients with high ERG expression intensity are significantly more likely to develop biochemical relapse and metastasis, and die of prostate cancer. The objective of this study was to determine the relationship between the intensity of ERG protein expression and the staging of prostate cancer and the formation of metastases in 635 samples. A retrospective cohort analysis was performed using immunohistochemistry reactions in tissue microarray samples taken from non-neoplastic and neoplastic prostate tissue from patients who underwent radical prostatectomies at a reference hospital from 2009 to 2016. For the ERG marker analysis, the samples were scored for the presence or absence of nuclear signals. Weak, moderate, or strong intensity of the nuclei of the observable tumor cells was considered to be positive markers. All told, 635 samples were evaluated, and the ERG expression was inconclusive in 9% of cases, while 30% were positive and 61% were negative. Of the samples with positive result: 25.8% were weak and focal, 53.2% were moderate, and 21% were strong. Finally, 21% of the cases with a positive ERG had a high Gleason score. Metastasis was detected in 41% of the patients who were ERG positive, and of these, the majority had moderate marking and were aged older than 60 years, although there was no statistically significant difference between the older and younger age groups. Patients with moderate to strong ERG staining had higher staging compared to the others, and no increase in metastasis was detected in patients with more intense ERG expression. More studies should be carried out to corroborate these results and to reach a consensus on the intensity and scoring of the expression levels of ERG markers." @default.
• W4384119818 created "2023-07-14" @default.
• W4384119818 creator A5002931963 @default.
• W4384119818 creator A5021596584 @default.
• W4384119818 creator A5042003308 @default.
• W4384119818 creator A5065825324 @default.
• W4384119818 date "2023-07-13" @default.
• W4384119818 modified "2023-09-24" @default.
• W4384119818 title "The relevance of ERG immunoexpression intensity for prostatic adenocarcinoma in radical prostatectomy of 635 samples" @default.
• W4384119818 cites W1778223853 @default.
• W4384119818 cites W1970564603 @default.
• W4384119818 cites W1974721873 @default.
• W4384119818 cites W1980426314 @default.
• W4384119818 cites W2006619657 @default.
• W4384119818 cites W2007843050 @default.
• W4384119818 cites W2028992206 @default.
• W4384119818 cites W2046003313 @default.
• W4384119818 cites W2048486094 @default.
• W4384119818 cites W2058795397 @default.
• W4384119818 cites W2059068580 @default.
• W4384119818 cites W2063102942 @default.
• W4384119818 cites W2072254840 @default.
• W4384119818 cites W2081782815 @default.
• W4384119818 cites W2095919110 @default.
• W4384119818 cites W2096800294 @default.
• W4384119818 cites W2117792530 @default.
• W4384119818 cites W2117936087 @default.
• W4384119818 cites W2166922670 @default.
• W4384119818 cites W2619715887 @default.
• W4384119818 cites W2789913193 @default.
• W4384119818 cites W2806267204 @default.
• W4384119818 cites W2883098787 @default.
• W4384119818 cites W2887867165 @default.
• W4384119818 cites W3044419981 @default.
• W4384119818 cites W4213422271 @default.
• W4384119818 cites W4225014817 @default.
• W4384119818 cites W4234651732 @default.
• W4384119818 cites W4315754639 @default.
• W4384119818 doi "https://doi.org/10.1111/apm.13330" @default.
• W4384119818 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37439391" @default.
• W4384119818 hasPublicationYear "2023" @default.
• W4384119818 type Work @default.
• W4384119818 citedByCount "0" @default.
• W4384119818 crossrefType "journal-article" @default.
• W4384119818 hasAuthorship W4384119818A5002931963 @default.
• W4384119818 hasAuthorship W4384119818A5021596584 @default.
• W4384119818 hasAuthorship W4384119818A5042003308 @default.
• W4384119818 hasAuthorship W4384119818A5065825324 @default.
• W4384119818 hasConcept C103796816 @default.
• W4384119818 hasConcept C118487528 @default.
• W4384119818 hasConcept C121608353 @default.
• W4384119818 hasConcept C126322002 @default.
• W4384119818 hasConcept C126894567 @default.
• W4384119818 hasConcept C142724271 @default.
• W4384119818 hasConcept C143998085 @default.
• W4384119818 hasConcept C193270364 @default.
• W4384119818 hasConcept C204232928 @default.
• W4384119818 hasConcept C2776235491 @default.
• W4384119818 hasConcept C2779013556 @default.
• W4384119818 hasConcept C2779399171 @default.
• W4384119818 hasConcept C2779466945 @default.
• W4384119818 hasConcept C2780192828 @default.
• W4384119818 hasConcept C2780827179 @default.
• W4384119818 hasConcept C2781182431 @default.
• W4384119818 hasConcept C71924100 @default.
• W4384119818 hasConceptScore W4384119818C103796816 @default.
• W4384119818 hasConceptScore W4384119818C118487528 @default.
• W4384119818 hasConceptScore W4384119818C121608353 @default.
• W4384119818 hasConceptScore W4384119818C126322002 @default.
• W4384119818 hasConceptScore W4384119818C126894567 @default.
• W4384119818 hasConceptScore W4384119818C142724271 @default.
• W4384119818 hasConceptScore W4384119818C143998085 @default.
• W4384119818 hasConceptScore W4384119818C193270364 @default.
• W4384119818 hasConceptScore W4384119818C204232928 @default.
• W4384119818 hasConceptScore W4384119818C2776235491 @default.
• W4384119818 hasConceptScore W4384119818C2779013556 @default.
• W4384119818 hasConceptScore W4384119818C2779399171 @default.
• W4384119818 hasConceptScore W4384119818C2779466945 @default.
• W4384119818 hasConceptScore W4384119818C2780192828 @default.
• W4384119818 hasConceptScore W4384119818C2780827179 @default.
• W4384119818 hasConceptScore W4384119818C2781182431 @default.
• W4384119818 hasConceptScore W4384119818C71924100 @default.
• W4384119818 hasIssue "9" @default.
• W4384119818 hasLocation W43841198181 @default.
• W4384119818 hasLocation W43841198182 @default.
• W4384119818 hasOpenAccess W4384119818 @default.
• W4384119818 hasPrimaryLocation W43841198181 @default.
• W4384119818 hasRelatedWork W108895284 @default.
• W4384119818 hasRelatedWork W1967410728 @default.
• W4384119818 hasRelatedWork W1982503259 @default.
• W4384119818 hasRelatedWork W2105726445 @default.
• W4384119818 hasRelatedWork W2139211733 @default.
• W4384119818 hasRelatedWork W2350150832 @default.
• W4384119818 hasRelatedWork W2402249956 @default.
• W4384119818 hasRelatedWork W2947266513 @default.
• W4384119818 hasRelatedWork W3150909901 @default.
• W4384119818 hasRelatedWork W3197039060 @default.
• W4384119818 hasVolume "131" @default.

• next